Feasibility and acceptability of artemisinin-based combination therapy for the home management of malaria in four African sites
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The Home Management of Malaria (HMM) strategy was developed using chloroquine, a now obsolete drug, which has been replaced by artemisinin-based combination therapy (ACT) in health facility settings. Incorporation of ACT in HMM would greatly expand access to effective antimalarial therapy by the populations living in underserved areas in malaria endemic countries. The feasibility and acceptability of incorporating ACT in HMM needs to be evaluated. METHODS: A multi-country study was performed in four district-size sites in Ghana (two sites), Nigeria and Uganda, with populations ranging between 38,000 and 60,000. Community medicine distributors (CMDs) were trained in each village to dispense pre-packaged ACT to febrile children aged 6-59 months, after exclusion of danger signs. A community mobilization campaign accompanied the programme. Artesunate-amodiaquine (AA) was used in Ghana and artemether-lumefantrine (AL) in Nigeria and Uganda. Harmonized qualitative and quantitative data collection methods were used to evaluate CMD performance, caregiver adherence and treatment coverage of febrile children with ACTs obtained from CMDs. RESULTS: Some 20,000 fever episodes in young children were treated with ACT by CMDs across the four study sites. Cross-sectional surveys identified 2,190 children with fever in the two preceding weeks, of whom 1,289 (59%) were reported to have received ACT from a CMD. Coverage varied from 52% in Nigeria to 75% in Ho District, Ghana. Coverage rates did not appear to vary greatly with the age of the child or with the educational level of the caregiver. A very high proportion of children were reported to have received the first dose on the day of onset or the next day in all four sites (range 86-97%, average 90%). The proportion of children correctly treated in terms of dose and duration was also high (range 74-97%, average 85%). Overall, the proportion of febrile children who received prompt treatment and the correct dose for the assigned duration of treatment ranged from 71% to 87% (average 77%). Almost all caregivers perceived ACT to be effective, and no severe adverse events were reported. CONCLUSION: ACTs can be successfully integrated into the HMM strategy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CONQUERING THE INTOLERABLE BURDEN OF MALARIA: WHAT’S NEW, WHAT’S NEEDED: A SUMMARY
BREMAN, J. G., ALILIO, M. S., & MILLS, A. (2004) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2004.71.2_suppl.0700001 · Cited by 677 · cited 1×
“This demonstrates the potential of CMDs to increase access to care in underserved rural areas in Africa, where government health facilities are often under-utilized [11,12].”
BackgroundHow do patients use antimalarial drugs? A review of the evidence
Yeung, S., & White, N. J. (2005) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2004.01364.x · Cited by 124 · cited 1×
“Adherence to the full treatment course has been highlighted as a matter of concern [14-16].”
Background
Cited by
Linn, N. Y. Y., Kathirvel, S., Das, M., Thapa, B., Rahman, M. M., Maung, T. M., Kyaw, A. M. M., Thi, A., & Lin, Z. (2018) · Malaria Journal · doi:10.1186/s12936-018-2384-4 · Cited by 317
Mubi, M., Janson, A., Warsame, M., Mårtensson, A., Källander, K., Petzold, M. G., Ngasala, B., Maganga, G., Gustafsson, L. L., Massele, A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019753 · Cited by 155
“studies conducted in sub-Saharan Africa but they did not address compliance [5,32].”
BackgroundBanek, K., Lalani, M., Staedke, S. G., & Chandramohan, D. (2014) · Malaria Journal · doi:10.1186/1475-2875-13-7 · Cited by 125
Lemma, H., Löfgren, C., & San Sebastian, M. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-349 · Cited by 54
“While high levels of adherence (74-98%) have been found in most African studies [2,22,24,25], lower levels have been reported in a study from southern Sudan (40%) [20].”
Molecular Farming in Artemisia annua, a Promising Approach to Improve Anti-malarial Drug Production
Pulice, G., Pelaz, S., & Matías-Hernández, L. (2016) · Frontiers in Plant Science · doi:10.3389/fpls.2016.00329 · Cited by 53
Metadata
- Authors
- Ajayi, I. O., Browne, E. N., Garshong, B., Bateganya, F., Yusuf, B., Agyei-Baffour, P., Doamekpor, L., Balyeku, A., Munguti, K., Cousens, S., & Pagnoni, F.
- Venue
- Malaria Journal
- Published
- 2008-01-08
- Volume
- 7
- Issue
- 1
- Pages
- 6-6
- ISSN
- 1475-2875 (ISSN-L)
- OpenAlex
- W2083606760
- Cited by
- 136
- References
- 2
- FWCI
- 14.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.